NMPA

RSS

Linzess approved in China for IBS with constipation

Jan. 16, 2019

Chinese NMPA accepts IND for Asceltis Pharma's third HCV drug ASC-21

Jan. 3, 2019

Tyvyt approved in China for the treatment of Hodgkin's lymphoma

Dec. 27, 2018

Toripalimab first domestically produced anti-PD-1 MAb approved in China

Dec. 20, 2018

China becomes first country to approve roxadustat

Dec. 18, 2018

China SFDA clears phase I trial of A-319 in B-cell malignancies

Nov. 13, 2018

Elunate approved in China for colorectal cancer

Sep. 5, 2018

CFDA approves INDs for Innovent's IBI-101 and IBI-307

July 27, 2018

Luye cleared for phase I trials in China with LY-03012

June 21, 2018

CFDA grants priority review to Pharnext's PXT-3003 for CMT1A

June 14, 2018